Lineage Cell Therapeutics, Inc. Long-term Debt and Lease Obligation, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Long-term Debt and Lease Obligation, Current of $26.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent · last filed 2016-03-15
- 2015-12-31: Long-term Debt and Lease Obligation, Current $26.00K.
- 2015-09-30: Long-term Debt and Lease Obligation, Current $0.00.
- 2015-06-30: Long-term Debt and Lease Obligation, Current $3.00K.
- 2015-03-31: Long-term Debt and Lease Obligation, Current $17.31K.
| Period end | Long-term Debt and Lease Obligation, Current | Long-term Debt and Lease Obligation, Current as first filed |
|---|---|---|
| 2015-12-31 | $26.00K 10-K · filed 2016-03-15 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $17.31K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $31.00K 10-K · filed 2016-03-15 | $31.29K 10-K · filed 2015-03-11 |
| 2014-09-30 | $44.96K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $57.50K 10-Q · filed 2014-08-11 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |